Mutolo D, Bongianni F, Cinelli E, Pantaleo T. Depression of cough reflex by microinjections of antitussive agents into caudal ventral respiratory group of the rabbit. J Appl Physiol 109: 1002-1010, 2010. First published July 22, 2010 doi:10.1152/japplphysiol.00406.2010.-We have previously shown that the caudal nucleus tractus solitarii is a site of action of some antitussive drugs and that the caudal ventral respiratory group (cVRG) region has a crucial role in determining both the expiratory and inspiratory components of the cough motor pattern. These findings led us to suggest that the cVRG region, and possibly other neural substrates involved in cough regulation, may be sites of action of antitussive drugs. To address this issue, we investigated changes in baseline respiratory activity and cough responses to tracheobronchial mechanical stimulation following microinjections (30 -50 nl) of some antitussive drugs into the cVRG of pentobarbital-anesthetized, spontaneously breathing rabbits. [D-Ala 2 ,N-Me-Phe 4 ,Gly 5 -ol]-enkephalin (DAMGO) and baclofen at the lower concentrations (0.5 mM and 0.1 mM, respectively) decreased cough number, peak abdominal activity, and peak tracheal pressure and increased cough-related total cycle duration (TT). At the higher concentrations (5 mM and 1 mM, respectively), both drugs abolished the cough reflex. DAMGO and baclofen also affected baseline respiratory activity. Both drugs reduced peak abdominal activity, while only DAMGO increased TT, owing to increases in expiratory time. The neurokinin-1 (NK1) receptor antagonist CP-99,994 (10 mM) decreased cough number, peak abdominal activity, and peak tracheal pressure, without affecting baseline respiration. The NK 2 receptor antagonist MEN 10376 (5 mM) had no effect. The results indicate that the cVRG is a site of action of some antitussive agents and support the hypothesis that several neural substrates involved in cough regulation may share this characteristic.control of breathing; -opioid receptors; GABAB receptors; neurokinin receptors; expiratory activity -ol]-enkephalin (DAMGO), the GABA B receptor agonist baclofen, the neurokinin-1 (NK 1 ) receptor antagonist CP-99,994, and the NK 2 receptor antagonist MEN 10376. We also proposed (42) that several neural substrates involved in the regulation of cough (12,16,17,31,44,46,48,56,57) may be sites of action of antitussive drugs. In agreement with our previous suggestion and preliminary results (17, 42, 44) as well as the proposal by Bolser and colleagues (12, 49), the responsive sites may comprise, in particular, the caudal part of the ventral respiratory column (2), i.e., the so-called caudal ventral respiratory group (cVRG), where bulbospinal expiratory neurons are concentrated (6,30,63).Several morphological and electrophysiological lines of evidence indicate that cVRG expiratory neurons are probably not involved in respiratory rhythmogenesis since very likely they do not have medullary axon collaterals (6,14,30,41,63). However, microinjections of the broad-spectrum excitato...